Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients

Abstract

BackgroundPatients with low cardiovascular disease (CVD) risk potentially use preventive cardiovascular medication unnecessarily. Our aim was to identify various viewpoints and beliefs concerning the preventive CVD management of patients with low CVD risk using preventive cardiovascular medication. Furthermore, we investigated whether certain viewpoints were related to a preference for deprescription or the continuation of preventive cardiovascular medication.MethodsIn 2015, we purposively sampled patients from the intervention arm of the Evaluating Cessation of STatins and Antihypertensive Treatment In primary Care (ECSTATIC) trial in the Netherlands for this study. Participants made Q-sorts by ranking 43 statements concerning preventive CVD management from “totally disagree” to “totally agree”. These Q-sorts were analyzed using PQMethod 2.35 software. A varimax procedure presented the distinguishing viewpoints that were favored by our participants. We used group discussion quotations to underline our findings. For validation purposes, we asked participants how well each viewpoint fitted them.ResultsOf 291 invited patients, 33 participated. Thirty-one Q-sorts were analyzed. The following three viewpoints were found: 1) a controlling viewpoint, in which patients held the belief that monitoring blood pressure and cholesterol levels is important (n=13, of which seven had their medication deprescribed and six continued their medication); 2) an autonomous viewpoint, in which patients showed a dislike of medication (n=8, of which seven had their medication deprescribed and one had it continued); and 3) an afraid viewpoint, in which patients were fearful of developing CVD (n=8, of which two had their medication deprescribed and six had it continued). Seventy-four percent of the participants believed that the viewpoint to which they were assigned was a good fit.ConclusionThree well-discriminating viewpoints about preventive CVD management were determined. Knowing and recognizing these viewpoints is effective for general practitioners when discussing the deprescribing of preventive cardiovascular medications with patients and may be used to promote implementation of deprescription.

Exploring how GPs discuss statin deprescribing with older people: a qualitative study

“…23 Patient attitudes and preferences towards deprescribing of CV medications appears to vary. 28 This supports the idea that discussing these considerations is important regardless of a patient's desired level of involvement in a final decision. GPs in this study acknowledged patient values and preferences as important, although there were differences among GPs in how they were discussed, and whether they were discussed.…”

Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial

“…It is remarkable that 35% of the participants in the intervention group of the ECSTATIC study did not attempt to have their medication deprescribed. Based on the findings of two of our previous studies, possible reasons for not doing an attempt are, for example, fear of the consequences of deprescribing, fear of cardiovascular events, the lack of negative effects of the medication participants experienced, or the GPs’ doubts about deprescribing [ 17 , 46 ]. Furthermore, only 27% of the participants in the intervention group persisted in quitting, while 65% of the participants did attempt to have their medication deprescribed.…”

A scoping review of Q-methodology in healthcare research

“…Face-to-face administration of the Q-sorting task was by far the most common approach to data collection. In many instances, this occurred in conjunction with another method like interviews/post-sorting questions, [ 129 , 130 ] focus groups/group discussions, [ 131 , 132 ] a think-aloud task, [ 23 ] or observations, [ 88 , 133 ] to capture information that clarified participants’ placement of the Q-set or provide additional insights into the topic. Perhaps due to the sensitive nature of many aspects of healthcare, mail-out and online forms of collecting Q-data were less common, although several software programs were used for online data collection.…”